Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Medicure raises $40 million in offering, deal

Medicure (TSX:MPH; MCU) raised US$15 million in a private placement of 13 million shares at US$1.15, which

Read the full 176 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE